【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 Data Analysis
1.4 List of Primary & Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market Variables, Trends& Scope
3.1 Companion Diagnostics: Categorization
3.1.1 Screening and detection
3.1.2 Prognosis
3.1.3 Theranostics
3.1.4 Monitoring
3.1.5 Recurrence
3.2 Market Segmentation & Scope
3.2.1 Market Driver Analysis
3.2.1.1 Rising adoption of companion diagnostics
3.2.1.2 Accelerating demand for targeted cancer treatment & tailored drugs
3.2.1.2.1 Cancer incidence rate,2016
3.2.1.3 Technological advancements pertaining to sequencing
3.2.1.4 Collaborations between diagnostic and pharma entities
3.2.1.4.1 Business models that benefit CDx developers in early partnering deals
3.2.1.5 Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges associated with reimbursement
3.2.2.2 Robustness of the financing environment for diagnostic and research tools companies
3.2.2.3 Laboratory developed tests anticipated to reduce adoption of CDx
3.3 Penetration & Growth Prospect Mapping for Therapeutic Area, 2016
3.4 Development of NGS based Companion Diagnostics
3.4.1 Associated operational challenges
3.4.1.1 Assay turnaround time
3.4.1.2 Sample quantity
3.4.1.3 Unavailability of CROs with CLIA NGS capabilities
3.4.2 Technical and analytical challenges for NGS assays in the clinic
3.4.2.1 Design & QC standardization
3.4.2.2 Post analytical challenges
3.4.2.3 Unavailability of CROs with CLIA NGS capabilities
3.4.3 Strategic challenges for drug and diagnostic developers
3.5 Companion Diagnostics Reimbursement Environment
3.5.1 Issues in technology assessment and payer decision making
3.5.2 Potential risks and benefits of pharmacogenomics from the payer perspective
3.6 Companion Diagnostics Regulatory Environment
3.6.1 Companion diagnostics regulatory environment, U.S.
3.6.2 Companion diagnostics regulatory environment, Europe
3.6.3 Companion diagnostics regulatory environment, Asia Pacific
3.7 Companion Diagnostics Regulatory Issues & Recall
3.7.1 Dako FDA warning letter
3.7.2 HercepTest recall
3.7.3 Cobas KRAS test recall
3.7.4 Cobas BRF V600E test recall
3.7.5 Leica Bond HER2 IHC system
3.8 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) – SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.9 Industry Analysis – Porter’s
Chapter 4 Pharmacogenomics Technology: Therapeutic Area Estimates & Trend Analysis
4.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market: Therapeutic Area Movement Analysis
4.2 Oncology
4.2.1 Global oncology market, 2014 – 2025 (USD Million)
4.2.2 Lung cancer
4.2.2.1 Global lung cancer market, 2014 – 2025 (USD Million)
4.2.3 Breast cancer
4.2.3.1 Global breast cancer market, 2014 – 2025 (USD Million)
4.2.4 Colorectal cancer
4.2.4.1 Global colorectal cancer market, 2014 – 2025 (USD Million)
4.2.5 Cervical cancer
4.2.5.1 Global cervical cancer market, 2014 – 2025 (USD Million)
4.2.6 Other cancers
4.2.6.1 Global other cancers market, 2014 – 2025 (USD Million)
4.3 Neurology
4.3.1 Global neurology market, 2014 – 2025 (USD Million)
4.4 Cardiovascular Diseases
4.4.1 Global cardiovascular diseases market, 2014 – 2025 (USD Million)
4.5 Immunological Disorders
4.5.1 Global immunological disorders market, 2014 – 2025 (USD Million)
4.6 Other Disorders
4.6.1 Global other disorders market, 2014 – 2025 (USD Million)
Chapter 5 Pharmacogenomics Technology: Technology Estimates & Trend Analysis
5.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market: Technology Movement Analysis
5.2 Polymerase Chain Reaction(PCR)
5.2.1 Global polymerase chain reaction market, 2014 – 2025 (USD Million)
5.3 In-situ Hybridization
5.3.1 Global in-situ hybridization market, 2014 – 2025 (USD Million)
5.4 Immunohistochemistry
5.4.1 Global immunohistochemistry market, 2014 – 2025 (USD Million)
5.5 Sequencing
5.5.1 Global sequencing market, 2014 – 2025 (USD Million)
5.6 Other Technologies
5.6.1 Global other technologies market, 2014 – 2025 (USD Million)
Chapter 6 Pharmacogenomics Technology: Regional Estimates & Trend Analysis, by Therapeutic Area & Application
6.1 Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.2 Market, by technology, 2014 – 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.2.4.2 Market, by technology 2014 – 2025 (USD Million)
6.3 Europe
6.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.3.4 UK
6.3.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.3.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.4.4 China
6.4.4.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.4.4.2 Market, by technology, 2014 – 2025 (USD Million)
6.5 Latin America
6.5.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.5.2 Market, by technology, 2014 – 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.5.3.2 Market, by technology, 2014 – 2025 (USD Million)
6.6 MEA
6.6.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.6.2 Market, by technology, 2014 – 2025 (USD Million)
6.6.3 South Africa
6.6.3.1 Market, by therapeutic area, 2014 – 2025 (USD Million)
6.6.3.2 Market, by technology, 2014 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Illumina Inc.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 F Hoffman La Roche
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Qiagen NV
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Myriad Genetics Inc.
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Agilent Technologies
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Foundation Medicine, Inc
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Leica Biosystems Nussloch GmBH
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Merck & Co Inc
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Oxford Cancer Biomarkers Ltd.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Astra Zeneca
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Thermo Fisher Scientific, Inc.
7.3.11.1 Company Overview
7.3.11.2 Financial Performance
7.3.11.3 Product Benchmarking
7.3.11.4 Strategic Initiatives
7.3.12 Beckman Coulter Inc.
7.3.12.1 Company Overview
7.3.12.2 Financial Performance
7.3.12.3 Product Benchmarking
7.3.12.4 Strategic Initiatives
7.3.13 Abbott Laboratories
7.3.13.1 Company Overview
7.3.13.2 Financial Performance
7.3.13.3 Product Benchmarking
7.3.13.4 Strategic Initiatives
7.3.14 Pfizer
7.3.14.1 Company Overview
7.3.14.2 Financial Performance
7.3.14.3 Product Benchmarking
7.3.14.4 Strategic Initiatives
7.3.15 Focus Diagnostics
7.3.15.1 Company Overview
7.3.15.2 Financial Performance
7.3.15.3 Product Benchmarking
7.3.15.4 Strategic Initiatives
7.3.16 AmeriPath Inc
7.3.16.1 Company Overview
7.3.16.2 Financial Performance
7.3.16.3 Product Benchmarking
7.3.16.4 Strategic Initiatives
7.3.17 Bristol Myers Squibb
7.3.17.1 Company Overview
7.3.17.2 Financial Performance
7.3.17.3 Product Benchmarking
7.3.17.4 Strategic Initiatives
7.3.18 Novartis Ag
7.3.18.1 Company Overview
7.3.18.2 Financial Performance
7.3.18.3 Product Benchmarking
7.3.18.4 Strategic Initiatives
【レポート販売概要】
■ タイトル：ファーマコゲノミクス技術/セラノスティクス/コンパニオン診断（CDx）の世界市場分析■ 英文：Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Therapeutic Area (Oncology Neurological, Cardiovascular, Immunology Disorders), By Technology, And Segment Forecasts, 2014 - 2025
■ 発行日：2017年6月9日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW70714019
■ 調査対象地域：グローバル
- シランの世界市場：有機シラン、モノシラン、クロロシランThe global silane market size is estimated to reach USD 1.70 Billion by 2020, registering a CAGR of 5.0% between 2015 and 2020. The increasing demand from consumers for road safety, improved fuel efficiency, and low environmental impact vehicles is expected to drive the demand of silanes in the next five years. Increase in sales of automobile is expected to drive the demand for silanes in most of …
- 顕微鏡検査の世界市場予測（～2022年）：光学顕微鏡、電子顕微鏡、AFM、STM、NSOM“Microscopy market is projected to register a CAGR of 5.7%.”The microscopy market is expected to register a CAGR of 5.7% to reach USD 7.39 billion by 2022 from USD 5.60 billion in 2017. Market growth can be attributed to the rising government and corporate funding for R&D in microscopy, technological advancements in microscopes, and the rising focus on nanotechnology and regenerative medicine. Whe …
- IoT（モノのインターネット）OS（オペレーティングシステム）の世界市場予測（～2022年）The IoT operating systems market is estimated to grow at a CAGR of 42.9% and expected to grow from USD 289.2 Million in 2017 to USD 1,721.3 Million by 2022, owing to the increase in social networking sites, which has led to sharing of large amounts of personal and private data across multiple platforms. There is an increased need for solutions to make sure that the personal and private data of ind …
- A型とB型インフルエンザウイルスの重複感染(Influenza A And B Infections)：世界の治験レビュー2014年下半期版Influenza A and B Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Influenza A and B Infections Global Clinical Trials Review, H2, 2014" provides data on the Influenza A and B Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza A and B Infections. It includes an overview …
- 先進創傷被覆材：企業動向Advanced Wound Dressings - Current and Future Players Summary Advanced dressings have steadily replaced traditional bandages and gauze materials in the treatment of a variety of wound indications, such as trauma wounds, burns, and chronic ulcerations. As fluid management, infection control, and physical protection become increasingly critical in wound healing, advanced dressings enjoy a greater ro …
- 世界の抗菌薬市場（2014-2024）Antibacterials - new analysis showing business trends, R&D, and revenue forecasts What's the future of medicines treating bacterial infections? For those drugs you get new sales predictions, also exploring research and development. Those treatments hold high potentials. There you assess results, progress, therapies, and opportunities. Knowledge facilitates success. Visiongain's new report forecast …
- バイオリアクターの世界市場2019-2023About this market The demand for single-use bioreactors has increased significantly in the global bioreactors market owing to their various attributes. Single-use bioreactors are simpler to use than stainless steel bioreactors because of the ease with which they can be set up for continuous processing. A single-use bioreactor that has been used in a fed-batch manufacturing process can be easily co …
- 発泡性ポリスチレン(EPS)の世界市場予測Expandable Polystyrene (EPS) 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Expandable polystyrene (EPS) market in the all-in-one report issued in a logical and easily accessible format. In …
- トラック隊列走行（プラトーニング）の世界市場予測（～2030年）“The rising number of road accidents due to driver error and increasing focus on reducing transportation operating cost will fuel the demand for the truck platooning market”The truck platooning market is projected to grow at a CAGR of 60.96% during the forecast period, and the market size is projected to grow from USD 37.6 million in 2021 to USD 2,728.7 million by 2030. The development of autonomo …
- Sezary Syndrome：グローバル臨床試験レビューH2, 2013Sezary Syndrome Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H2, 2013" provides data on the Sezary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sezary Syndrome. It includes an overview of the trial numbers and their recruitment status as …
- ディスクリートコンデンサの世界市場：セラミックコンデンサー、アルミコンデンサ、紙・プラスチックAC&DCフィルムコンデンサ、タンタルコンデンサAbout Discrete Capacitors A normal form of a capacitor is a one that preserves and discharges electrical energy without any loss of energy. A discrete capacitor, on the other hand, can have losses of electric current due to the nature of its capacitor components. Discrete capacitors can be made of different materials such as ceramic or plastic dielectric and also have different types of build-up d …
- チューインガムの世界市場2015-2019About chewing gum The concept of chewing gum is not new to mankind. The product gained popularity in 1971 in New York under the name Adams New York Chewing Gum. Apart from providing proper dental hygiene, chewing is known for having other benefits as well. Chewing gums are available in various sizes such as strips and pellets and flavors to attract children, teenagers, and adults. Technavio's anal …
- ガス絶縁開閉装置（GIS）の世界市場2015-2019About GIS Switchgear is a protection device and is a combination of different types of components such as circuit breakers, current transformers, potential transformers, lightning arrestors, protection relays, and disconnectors arranged in a logical manner. They are used in transmission and distribution of electric power and effectively protect equipment and circuits from unregulated power spikes. …
- 世界主要国におけるライノウイルス検査市場2015The report presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rhinovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- DLPプロジェクターの世界市場予測（～2020）The DLP projector market is expected to reach USD 5.52 Billion by 2020 at a CAGR of 6.3% between 2015 and 2020. One of the major factors driving the growth of the high-end DLP projector market is the increasing number of digital screens in professional cinema. Moreover, the ongoing digitalization in the education sector, especially in APAC countries, is expected to further drive the demand for DLP …
